Severe Neutropenia Consequent to Sustained-Release Procainamide
AUTOR(ES)
Mellino, Marcello
RESUMO
A patient with reversible severe neutropenia and relative eosinophilia caused by sustained-release procainamide is described. Significant early and very late complications of therapy with procainamide preparations have been rarely described so far. The important pharmacokinetic aspects of sustained release procainamide are discussed, and the postulated mechanisms of induction of blood dyscrasias are reviewed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=341612Documentos Relacionados
- EVALUATION OF SUSTAINED-RELEASE ACETAZOLAMIDE*†
- Trial of sustained-release tetracycline in the treatment of gonorrhoea.
- Evaluation of a sustained-release oral tetracycline in non-specific urethritis.
- Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant
- Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital.
